Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE), European Respiratory Journal, vol.31, issue.4, pp.869-73, 2008. ,
DOI : 10.1183/09031936.00111707
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, European Respiratory Journal, vol.23, issue.6, pp.932-978, 2004. ,
DOI : 10.1183/09031936.04.00014304
A; on behalf of the ECLIPSE Study Investigators: Lessons from ECLIPSE: a review of COPD biomarkers, Silverman EK and Agusti Thorax, vol.0, pp.1-7, 2013. ,
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study, Thorax, vol.64, issue.3, pp.211-216, 2009. ,
DOI : 10.1136/thx.2008.102079
Plasma protein profiles in early asthmatic responses to inhalation allergen challenge, Allergy, vol.145, issue.Suppl. 1, pp.47-54, 2009. ,
DOI : 10.1042/bj2650621
Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.72, issue.6, pp.1008-1019, 2001. ,
DOI : 10.1016/S1357-2725(97)00118-0
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease, Thorax, vol.61, issue.10, pp.849-53, 2006. ,
DOI : 10.1136/thx.2006.059808
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease: Table 1, Thorax, vol.183, issue.7, pp.670-676, 2013. ,
DOI : 10.1164/rccm.201008-1220OC
Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD, Respiratory Research, vol.165, issue.1, p.29, 2011. ,
DOI : 10.1001/archinte.165.8.891
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD, European Respiratory Journal, vol.34, issue.1, pp.95-102, 2009. ,
DOI : 10.1183/09031936.00156508
Localization of Lung Surfactant Protein D on Mucosal Surfaces in Human Tissues, The Journal of Immunology, vol.164, issue.11, pp.5866-70, 2000. ,
DOI : 10.4049/jimmunol.164.11.5866
Surfactant protein-D and pulmonary host defense, Respir Res, vol.1, pp.93-108, 2000. ,
Long-term stability and circadian variation in circulating levels of surfactant protein D, Immunobiology, vol.215, issue.4, pp.314-334, 2010. ,
DOI : 10.1016/j.imbio.2009.05.001
Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease, Biomarkers, vol.359, issue.2, pp.97-103, 2010. ,
DOI : 10.1183/09031936.02.00238702
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia??????This work was supported by the Danish Medical Research Council, an EU grant, contract number: QLK2-CT-2000-0035; the Novo Nordisk Foundation; Fonden til L??gevidenskabens Fremme; Ingemann O. Bucks Foundation and the Benzon Foundation., Clinical Immunology, vol.108, issue.1, pp.29-37, 2003. ,
DOI : 10.1016/S1521-6616(03)00042-1
Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction, BMC Pulmonary Medicine, vol.6, issue.Suppl, p.19, 2011. ,
DOI : 10.1080/15412550903051799
The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.11, pp.1207-1221, 2008. ,
DOI : 10.1183/09031936.00023907
Serum Surfactant Protein D: Biomarker of Chronic Obstructive Pulmonary Disease, Disease Markers, vol.32, issue.5, pp.281-288, 2012. ,
DOI : 10.1155/2012/509063
Serum Surfactant Protein D during Acute Exacerbations of Chronic Obstructive Pulmonary Disease, Disease Markers, vol.27, issue.6, pp.287-94, 2009. ,
DOI : 10.1155/2009/759304
Exhaled Metallic Elements and Serum Pneumoproteins in Asymptomatic Smokers and Patients With COPD or Asthma, Chest, vol.129, issue.5, pp.1288-97, 2006. ,
DOI : 10.1378/chest.129.5.1288
Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population, Respirology, vol.1820, issue.2, pp.296-303, 2015. ,
DOI : 10.1016/j.bbagen.2011.12.006
Surfactant protein A and surfactant protein D variation in pulmonary disease, Immunobiology, vol.212, issue.4-5, pp.381-416, 2007. ,
DOI : 10.1016/j.imbio.2007.01.003
A clinical study of hypersensitivity pneumonitis presumably caused by feather duvets, Annals of Allergy, Asthma & Immunology, vol.96, issue.1, pp.98-104, 2006. ,
DOI : 10.1016/S1081-1206(10)61047-2
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients, European Respiratory Journal, vol.27, issue.5, pp.902-909, 2006. ,
DOI : 10.1183/09031936.06.00109605
Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.12, pp.1211-1219, 2008. ,
DOI : 10.1164/rccm.200210-1130OC
What Does Minor Elevation of C-Reactive Protein Signify?, The American Journal of Medicine, vol.119, issue.2, pp.166-183, 2006. ,
DOI : 10.1016/j.amjmed.2005.06.057
Hypersensitivity Pneumonitis due to Bunashimeji Mushrooms in the Mushroom Industry, International Archives of Allergy and Immunology, vol.162, issue.3, pp.241-249, 2005. ,
DOI : 10.1164/ajrccm.162.3.9910080
Budesonide/Formoterol Enhances the Expression of Pro Surfactant Protein-B in Lungs of COPD Patients, PLoS ONE, vol.180, issue.12, p.83881, 2013. ,
DOI : 10.1371/journal.pone.0083881.t003
Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease, Experimental and Therapeutic Medicine, vol.8, issue.4, pp.1313-1330, 2014. ,
DOI : 10.3892/etm.2014.1865
Blood biomarkers and measures of pulmonary function???A study from the Swedish twin registry, Respiratory Medicine, vol.106, issue.9, pp.1250-1257, 2012. ,
DOI : 10.1016/j.rmed.2012.05.004
Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease, Multidisciplinary Respiratory Medicine, vol.8, issue.1, pp.36-51, 2013. ,
DOI : 10.1186/1465-9921-9-13
Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study, BMC Pulmonary Medicine, vol.31, issue.1, p.13, 2007. ,
DOI : 10.1016/j.cyto.2005.02.006
Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.55, issue.9, pp.887-95, 2014. ,
DOI : 10.1016/j.imbio.2012.08.272
COPD association and repeatability of blood biomarkers in the ECLIPSE cohort, Respiratory Research, vol.54, issue.1, p.146, 2011. ,
DOI : 10.1016/S0895-4356(00)00314-0
Could symptoms and risk factors diagnose COPD? Development of a Diagnosis Score for COPD, Clinical Epidemiology, vol.4, pp.247-55 ,
DOI : 10.2147/CLEP.S34985